Target intelligence / Profile preview

RNA, U1 small nuclear 65, pseudogene (RNU1-65P)

Target: RNU1-65P
Molecular classification: Other (Pseudogene)

Overview

RNU1-65P encodes a pseudogene of the U1 small nuclear RNA gene family, located at cytogenetic region 10q23.1. Unlike the canonical functional U1 small nuclear RNA genes—which are key components of the spliceosome and essential for mRNA splicing in eukaryotic cells—RNU1-65P does not produce a functional RNA or protein product and is not involved in splicing or other known biological processes. As a pseudogene, it lacks protein-coding capacity and is not considered an actionable therapeutic target. There are no known functional associations with disease, drug interactions, or biomarker uses for RNU1-65P.

Other names: RNU1-65P

Beyond the preview

Go deeper on RNA, U1 small nuclear 65, pseudogene (RNU1-65P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 65, pseudogene (RNU1-65P).

Explore the full profile